The Effect of Omega-3 prescription on serum levels of Interleukin-6 and Interleukin-1 beta in patients with traumatic brain injury
Phase 3
Recruiting
- Conditions
- traumatic brain injury.Diffuse traumatic brain injury
- Registration Number
- IRCT20180223038838N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients with traumatic brain injur
Exclusion Criteria
History of seafood susceptibility
History of severe and uncontrollable hypertension
Consumption of immunosuppression
Consumption of antiepileptic
Liver Dysfunction
Kidney disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glasgow Coma Scale. Timepoint: Before the intervention and seven days after the intervention. Method of measurement: Glasgow coma scale score.;Serum level of interleukin-6. Timepoint: Before the intervention and seven days after the intervention. Method of measurement: Enzyme-linked immunosorbent assay (ELISA ).;Serum level of interleukin-1 beta. Timepoint: Before the intervention and seven days after the intervention. Method of measurement: Enzyme-linked immunosorbent assay (ELISA ).
- Secondary Outcome Measures
Name Time Method